IL-2 based cancer immunotherapies: An evolving paradigm

S Rokade, AM Damani, M Oft, J Emmerich - Frontiers in Immunology, 2024 - frontiersin.org
Discovered over 4 decades ago in the supernatants of activated T cells, interleukin-2 (IL-2)
is a potent pleiotropic cytokine involved in the regulation of immune responses. It is required …